Top Collagen and Gelatin Companies

Collagen and Gelatin Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.43 Billion in 2025 to USD 2.39 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026–2033).

The collagen and gelatin market is somewhat fragmented, with a small number of large and medium-sized players generating the majority of revenue. Major players are developing, testing, and introducing more efficient collagen and gelatin products, employing various strategies, entering into strategic agreements and contracts, and completing mergers and acquisitions. 'Integra Lifesciences ', 'DSM ', 'Nitta Gelatin Inc. ', 'Collplant Biotechnologies Ltd. ', 'Collagen Solutions Plc ', 'Regenity ', 'Symatese ', 'Gelita AG ', 'Tessenderlo Group (BU PB Liner) ', 'Smith & Nephew Plc ', 'Zimvie Inc. ', 'Jellagen ', 'MatriceL GmbH ', 'Rousselot ', 'Weishardt ', 'Xiamen Hyfine Gelatin Co., Ltd. ', 'Geistlich Pharma AG ', 'Synerheal Pharmaceuticals ', 'Bioregen Technologies ', 'Meril Life Sciences Pvt. Ltd. '

The use of gelatin and collagen-based biomaterials in regenerative medicine has been heavily promoted in recent years. The growth of the collagen and gelatin market is being sped up as a result of the increased use of this method for environmental and medical purposes. The primary driver of the growth of the gelatin market is the rise in demand for gelatin as a food stabilizer, which results in an increase in food products like pasta, ice cream, yogurt, jam, and other related goods. Since collagen is used to treat wounds and make a variety of medicines, there was a lot of demand for it on the collagen and gelatin market.

The 21st Century Cures Act was enacted into law in the United States in December 2016.This act created a brand-new designation for Regenerative Medicine Advanced Therapy. This also included the introduction of procedures for expedited regenerative medicine approval. Companies' R&D efforts to develop new regenerative medicine products increased as a result.

Market in North America accounted for the largest revenue share in the global collagen & gelatin market in 2021. due to an increase in the number of surgeries for soft-tissue augmentation and investments and infrastructure in healthcare. In addition, the region's market for synthetic tissue and biomaterials is seeing revenue growth thanks to new product innovations, active participation in research and development (R&D) for the creation of novel cosmetic, cardiovascular, and bone marrow treatments. Diseases like osteoarthritis and rheumatoid arthritis are on the rise as a result of rising obesity and sedentary lifestyles, both of which are major contributors to the market's revenue growth. MD Logic Health introduced a brand-new, specialized marine collagen on May 25, 2022. The collagen is made with a unique blend of co-factors that include Vitamins C, A, Zinc, Copper, and Biotin. Collagen production can be accelerated with the help of cofactors.